SynthesisFrontiers in oncology2026

Dynamic circulating tumor DNA profiling of ESR1 mutations in HR+/HER2- advanced breast cancer: from prognostic biomarker to clinical decision-making - a comprehensive review.

Saiyu Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.